Management of elevated TSH levels in adult patients in primary care: Introduction of the New Guideline (S2k) of the German college of general practitioners and family physicians (DEGAM)

被引：0

作者：

Voigt K. ^{[1
]}

Bergmann A. ^{[1
]}

Bründel K.-H. ^{[1
]}

Schübel J. ^{[1
]}

机构：

[1] Bereich Allgemeinmedizin/Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, Dresden

来源：

Zeitschrift für Allgemeinmedizin | 2017年 / 93卷 / 4期

关键词：

Guideline; Hypothyroidism; Primary care; Thyroid gland;

D O I：

10.3238/zfa.2017.0150-0155

中图分类号：

学科分类号：

摘要：

Background: Laboratory tests of the thyroid-stimulating hormone (TSH) are often requested in medical care and result in physician-patient consultations about "elevated TSH" and the need for further diagnostic and therapeutic decisions. This article presents the new DEGAM guideline "Elevated TSH levels in family medicine" and the discussion of its key recommendations on diagnostics and treatment in patients with elevated TSH levels. Methods: The guideline is based on a literature review of PubMed and the Cochrane database on elevated TSH le-vels/hypothyroidism in the setting of primary care. Using the Delphi method the recommendations were consented. with lected members of the German Societies of Internal Medicine and Endocrinology. Results: An elevated TSH level is defined by > 4.0 mU/l. The recommendations for diagnostics sensitize the user to early detection and medical intervention, and the need for interdisciplinary cooperation in case of complications and potentially dangerous courses. Furthermore, advice for preventing early pathologization in case of asymptomatic slightly altered TSH levels is given. Treatment recommendations point out the requirements and conditions for drug treatment, and also when such a therapy is unnecessary. Conclusions: Elevated TSH levels can be interpreted re further diagnostics and therapy. In particular, the case of latent hypothyroidism creates uncertainties for which the guideline attempts to provide guidance. Critically reflection of diagnostic and therapeutic procedures should help to prevent overdiagnosis. The guideline sensitizes the user to the active involvement of patients in decisionmaking to support highest possible adherence. © Deutscher Ärzteverlag.

引用

页码：150 / 155

页数：5

共 12 条

[1]

Schubel J., Voigt K., Brundel K.-H., Berg-Mann A., Erhöhter TSH-wert in der Hausarztpraxis (DEGAM-leitlinie Nr. 18)

[2]

Hamilton T.E., Davis S., Onstad L., Ko-Pecky K.J., Thyrotropin levels in a population with no clinical, autoantibo-dy, or ultrasonographic evidence of thyroid disease: Implications for the diagnosis of subclinical hypothyroi-dism, J Clin Endocrinol Metab, 93, pp. 1224-1230, (2008)

[3]

Hollowell J.G., Staehling N.W., Flanders W.D., Et al., Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III), J Clin Endocrinol Metab, 87, pp. 489-499, (2002)

[4]

Fink H., Hintze G., Die Autoimmunthy-reoiditis (Hashimoto-Thyreoiditis): Ak-tuelle Diagnostik und Therapie, Med Klin, 105, pp. 485-493, (2010)

[5]

Zophel K., Gruning T., Roggenbuck D., Wunderlich G., Kotzerke J., On specificity of 2nd generation TSH receptor auto-antibody measurements, Clin Lab, 54, pp. 243-249, (2008)

[6]

Vanderpump M.P.J., Tunbrldge W.M.G., French J.M., Et al., The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whick-ham Survey, Clin Endocrinol, 43, pp. 55-68, (1995)

[7]

Meyerovitch J., Rotman-Pikielny P., Sherf M., Battat E., Levy Y., Surks M.I., Serum thyrotropin measurements in the community: Five-year follow-up in a large network of primary care physicians, Arch Intern Med, 167, pp. 1533-1538, (2007)

[8]

Khandelwal D., Tandon N., Overt and subclinical hypothyroidism: Who to treat and how, Drugs, 72, pp. 17-33, (2012)

[9]

Choosing Wisely

[10]

Pham C.B., Shaughnessy A.F., Should we treat subclinical hypothyroidism?, BMJ, 337, (2008)

← 1 2 →